Jun 08, 2020
Neurelis Announces Rapid and Broad Payer Coverage of the Company's Flagship Product, VALTOCO® (Diazepam Nasal Spray)
May 12, 2020
Worldwide Epilepsy Markets to 2024
Mar 26, 2020
Bio-Pharm Solutions Expands from Epilepsy to Neurodegenerative Diseases Aiming for IPO
Mar 02, 2020
Neurelis Announces Commercial Availability of VALTOCO® (Diazepam Nasal Spray) for Seizure Cluster Rescue
Jan 13, 2020
Neurelis Announces FDA Approval for Seizure Rescue Treatment VALTOCO® (Diazepam Nasal Spray) that Incorporates the Science of Intravail® for Consistent and Reliable Absorption
Jan 09, 2020
Mercaptor Discoveries Announces Preclinical Program in Epilepsy
Dec 06, 2019
SK life science to Present Latest Cenobamate Data at the American Epilepsy Society 2019 Annual Meeting
Nov 25, 2019
UCB Announces availability of NAYZILAM® (midazolam) Nasal Spray CIV, the first and only nasal rescue treatment for seizure clusters in the U.S.
Oct 24, 2019
World Federation of Neurology Reveals New Frontiers in Epilepsy Treatment for Children, Pregnant Women and, New Links Between ADHD and Epilepsy at 24th Annual World Congress of Neurology, Dubai, Oct 27 - 31
Oct 22, 2019
Neurelis Announces Three Poster Presentations At The Annual Meeting Of The Child Neurology Society
Jul 29, 2019
Epygenix Therapeutics Receives IND Approval of EPX-100 for the Treatment of Dravet Syndrome
Jun 24, 2019
Epygenix Therapeutics Submits Investigational New Drug Application for EPX-100 to the U.S. FDA for the Treatment of Patients With Dravet Syndrome
May 20, 2019
UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.
May 16, 2019
Cerebral Therapeutics(TM) to Present Clinical Data at Antiepileptic Drug and Device Trials XV Conference
Apr 29, 2019
Neurelis Announces Two Poster Presentations At The Annual Meeting Of The American Academy Of Neurology
Feb 04, 2019
SK life science announces FDA acceptance of NDA submission for cenobamate, an investigational antiepileptic drug
Oct 26, 2018
Global Epilepsy Market and Competitive Landscape 2014-2023: Pipeline, Epidemiology, Market Valuations, Product Sales, Market Forecast, Product Forecasts, and Market Shares
Oct 02, 2018
Global Epilepsy Drugs Market 2018-2022: Use of Genetics as Therapeutics and Diagnostic Modality Gaining Momentum
Aug 13, 2018
FDA Accepts New Drug Application (NDA) to review Midazolam Nasal Spray, an investigational product for the acute treatment of seizure clusters
Apr 23, 2018
SK life science presents data on the investigational antiepileptic drug, cenobamate, at the American Academy of Neurology Annual Meeting 2018